Chickenpox vaccine study for healthy children in Vietnam
Treatments studied
Part of Infections clinical trials.
This trial tests a chickenpox vaccine in healthy children ages 1 to 12 to see how well it works and if it's safe. If your child has never had chickenpox or the vaccine, or had one dose at least 3 months ago, they may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is healthy and between 1 and 12 years old.
- If your child is 1 year old, they must never have had the chickenpox vaccine. For children 2–12, they can have had no chickenpox vaccine or just one dose given at least 3 months ago.
- Your child must not have a history of chickenpox infection or recent exposure (within 4 weeks).
- Your child must not have serious allergies, immune system problems, bleeding disorders, or uncontrolled long-term illnesses.
- Your child must not have taken certain medications (like steroids or other study drugs) within the specified time frames before screening.
- Your child must be otherwise healthy with no fever, skin issues at the injection site, or acute illness on the day of vaccination.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lower-dose varicella (chickenpox) vaccine in healthy children. It aims to see if the vaccine works and is safe. Your child may be able to join if they haven't had chickenpox or the vaccine before.
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
This trial tests a live chickenpox vaccine given at the same time as the MMR or DTaP shot for children ages 18 to 24 months. It may help protect your child from chickenpox while keeping their regular vaccine schedule on track.
This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.
This study tests a combined booster vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. It aims to see how well the vaccine boosts the immune system and if it is safe.
This study tests a new chickenpox vaccine for healthy children ages 12 to 15 months. It aims to see if the vaccine is safe and helps protect against chickenpox.
Hear when a new Varicella (Chickenpox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.